Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
Latest Information Update: 07 Nov 2023
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 03 Nov 2022 Status changed from active, no longer recruiting to completed.
- 04 Jul 2022 Results from NCT02940262; NCT03353740, NCT03396874, retrospectively evaluating disease extent in men stratified by EAU BCR risk groups or biochemical persistence ,presented at the 37th Congress of the European Association of Urology
- 10 Mar 2022 Planned End Date changed from 1 Jan 2023 to 1 Aug 2022.